Skip to content

Clinical trials

Scleroderma, Diffuse trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Scleroderma, Diffuse Country / region: Australia Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20101
20131
20171
20192
20201
20211
20221
20232
20243
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting8
Completed4
Active, not recruiting3
Suspended1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
CSL Behring2
GlaxoSmithKline2
Actelion1
Bristol-Myers Squibb1
Certa Therapeutics1
Corbus Pharmaceuticals Inc.1
Emerald Health Pharmaceuticals1
Gilead Sciences1
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company1
Mediar Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Scleroderma, Diffuse18
Scleroderma, Systemic7
Connective Tissue Diseases4
Lung Diseases, Interstitial4
Arthritis, Rheumatoid3
Myositis3
Sclerosis3
Autoimmune Diseases2
Skin Diseases2
Addison Disease1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.